Added to YB: 2024-09-06
Pitch date: 2024-09-04
AVCR.V [neutral]
Avricore Health Inc.
-69.23%
current return
Author Info
Wolf of Oakville takes a magnifying glass to Canadian small cap stocks. Sign up for the newsletter.
Company Info
Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes.
Market Cap
CAD 9.1M
Pitch Price
CAD 0.26
Price Target
N/A
Dividend
N/A
EV/EBITDA
-14.83
P/E
-4.43
EV/Sales
4.46
Sector
Health Care Technology
Category
growth
Avricore Health $AVCR.V FINS Review
AVCR.V (fair value, questions remain): Revenue +91% Q2, +84% YTD. Margins volatile (35.4% Q2, 41.7% LY). MC $28M, 7x sales. Profitable, but cash burn concerns. 20% SBC plan risk. Shoppers sole client, Rexall pilot slow. TAM promising if executed. Valuation fair. 3-star rating.
Read full article (3 min)